← Leaderboards
Zhongmin Alex Ma
Washington University
$5,148,739
Attributed
$5,148,739
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $990.9K · FY2005–17$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$5,148,739 · 8
By mechanism
R01$2,416,733 · 2
R44$1,490,762 · 1
R21$461,888 · 1
R43$450,000 · 2
P41$329,356 · 2
Top collaborators
No co-investigators on record.
Most similar at Washington University
Same institution · by research overlap
- John W Turk$9,203,839
- Robert E Schmidt$4,976,339
- Richard W Gross$19,685,901
- S Bao$107,064
- Haowei Song$157,044
Others in their field
Top investigators on “Play”
- Lawrence Corey · Fred Hutchinson Cancer Center$428,785,907
- Chanza Baytop · Westat, Inc.$271,217,917
- Richard K. Wilson · Washington University$200,435,757
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Jeffrey P Krischer · University Of South Florida$191,869,794
- Constance Ann Benson · University Of California, San Diego$187,132,366
Research focus
PlayReportingDiabetes MellitusPhospholipase A2PreventCellsPhosphorylationAttenuatedRattusMediatingLinkBlood GlucoseEventLeadSignal TransductionPre-ClinicalCommercial ApplicationBeta CellMichiganPathogenesisCell LinePharmaceutical PreparationsBiomedical ResourceInsulin
Grant awards (17)
Novel ClopNPT for the treatment of acute coronary syndrome$225,000
R43 · FY2017 · HL · contact PI
Development of DT-110 as an oral therapeutic for type 2 diabetes$724,860
R44 · FY2016 · DK · contact PI
Development of DT-110 as an oral therapeutic for type 2 diabetes$765,902
R44 · FY2015 · DK · contact PI
Development of DT-109 as an oral therapeutic for type 2 diabetes$225,000
R43 · FY2015 · DK · contact PI
PROTECTION OF PANCREATIC BETA-CELLS BY GROUP VIA PHOSPHOLIPASE A(2)$8,316
P41 · FY2011 · RR · contact PI
Mechanisms of neurodegeneration and brain iron accumulation$381,375
R01 · FY2010 · NS · contact PI
Mechanisms of neurodegeneration and brain iron accumulation$381,375
R01 · FY2009 · NS · contact PI
Role of defective clearance of apoptotic beta-cell in pathogenesis of T1D$207,638
R21 · FY2008 · DK · contact PI
The Function of Phospholipase A2 in Islet Beta-cells$306,366
R01 · FY2007 · DK · contact PI
Role of defective clearance of apoptotic beta-cell in pathogenesis of T1D$254,250
R21 · FY2007 · DK · contact PI
The Function of Phospholipase A2 in Islet Beta-cells$315,516
R01 · FY2006 · DK · contact PI
The Function of Phospholipase A2 in Islet Beta-cells$323,109
R01 · FY2005 · DK
The Function of Phospholipase A2 in Islet Beta-cells$323,109
R01 · FY2004 · DK
The Function of Phospholipase A2 in Islet Beta-cells$385,883
R01 · FY2003 · DK
CLONING &EXPRESSION OF GROUP IV CYTOSOLIC CA2+ DEPENDENT PHOSPHOLIPASE$157,506
P41 · FY2002 · RR
CLONING &EXPRESSION OF GROUP IV CYTOSOLIC CA2+ DEPENDENT PHOSPHOLIPASE$157,506
P41 · FY2001 · RR
CLONING &EXPRESSION OF GROUP IV CYTOSOLIC CA2+ DEPENDENT PHOSPHOLIPASE$6,028
P41 · FY2000 · RR